Melbourne-based healthtech company Eyetelligence, which uses advanced artificial intelligence (AI) technology and retinal imaging to screen for eye and systemic diseases, has received an US$12 (AU$18) million investment from New York-based healthtech company creation platform Ascertain.
The…
Source: hospitalhealth.com.au – Read more
